Document:

EX-10.12

 Exhibit 10.12 

CONFIDENTIAL SEPARATION AGREEMENT 

This Confidential Separation Agreement (the “Agreement”), dated as of December 17, 2013, is entered into by and between
David N. Jonas (“Executive”) and PharMedium Healthcare Corporation (the “Company”). 
 Recitals

 A. Executive has been employed by the Company as its Chairman of the Board and Chief Executive Officer pursuant to a Supplemental
Employment Agreement dated October 11, 2007 (the “Supplemental Employment Agreement”). All capitalized terms used in this Agreement without definition herein shall have the meanings given to them in the Supplemental Employment
Agreement. 
 B. The Company is entering into a merger transaction (the “Merger”), that will result in a change of control
of the Company. As a result of the Merger, the Company and Executive have agreed that Executive’s employment will terminate without “cause” effective as of the Separation Date (defined below). 

C. Pursuant to Section 7 of the Supplemental Employment Agreement, Executive is entitled to certain payments and benefits following his
termination of employment without “cause”, provided he signs and does not revoke a release of claims in a form approved by the Company. 

D. This Agreement constitutes the release of claims contemplated by Section 7 of the Supplemental Employment Agreement, and is entered
into in order to amicably resolve all payment and other obligations the Company owes to Executive upon termination of his employment and to resolve any disputes between them that arise out of or relate to Executive’s employment with the Company
and termination of employment. 
 NOW, THEREFORE, the parties agree, in consideration of the provisions described below, as follows: 

1. Termination. 
 (a)
Executive’s employment with the Company is terminated without “cause” effective as of the effective date of the Merger (the “Separation Date”). 

(b) Effective as of the Separation Date, Executive resigns as a director and/or officer of the Company and any Subsidiary for which he served
in any such capacity. Executive further resigns as a trustee or from any other similar official capacity from any Company benefit plans or related trusts with which he may have served. Executive shall execute promptly such other documents evidencing
any other resignations as the Company shall reasonably request. 

 2. Payment on Separation. 

(a) The Company shall pay to the Executive, on the Separation Date, an amount equal to the following (to the extent not already paid by the
Company) whether or not he executes this Agreement: 
 (i) Executive’s Base Salary through the Separation Date; 

(ii) Reimbursement for Executive’s business expenses incurred through the Separation Date; and 

(iii) Any other amounts required to be paid to Executive under applicable law in connection with the termination of his employment. 

(b) The Company shall pay to the Executive, on the Separation Date, the sum of Four Hundred Five Thousand and 00/100 Dollars ($405,000),
representing the Executive’s 2013 Annual Bonus under the Management Incentive Compensation Plan (MICP) based on his target (consistent with the Company’s historical course of dealing with executive bonuses). 

3. Additional Consideration. In consideration for, and subject to Executive refraining from revoking, the release and covenant not to
sue in Section 4 below: 
 (a) The Company shall pay Executive, on the Separation Date, the sum of Two Million Six Hundred Sixty-Five
Thousand and 00/100 Dollars ($2,665,000.00), which amount represents two times the sum of (i) Executive’s annual Base Salary at the highest rate in effect for Executive during the two-year period immediately prior to the Separation Date,
plus (ii) Executive’s highest Annual Bonus received during each of the two full 12-month periods immediately preceding the Separation Date. 

(b) Throughout the period beginning on the Separation Date and ending on the third anniversary of the Separation Date, the Company at its
expense shall provide Executive and his spouse and dependents with continuation of the health benefits coverage as in effect immediately prior to the Separation Date. If at any time during that three-year period such coverage is not available to
Executive and his spouse and dependents under the Company’s health benefits existing as of the Separation Date, the Company shall procure at its expense and provide to Executive and his spouse and dependents replacement health benefits coverage
substantially identical to the health benefits coverage Executive and his spouse and dependents had as of immediately prior to the Separation Date. If such continuation of health care coverage results in Executive having any federal, state or local
tax liability or obligation that is greater than the tax liability Executive had with respect to health coverage benefits prior to the Separation Date, the Company will pay Executive a gross-up payment to defray the additional taxes. 

  
 2 

 (c) Effective as of the Separation Date, any Company restricted stock held by the Executive shall
be deemed 100% vested. 
 (d) For the ten (10) business days immediately following the Separation Date, Executive shall be provided with
access to his current office at the Company without charge to allow Executive to transition his records, files and personal effects in a manner consistent with this Agreement, the Supplemental Employment Agreement and the letter agreement between
Executive and CDRF Topco, Inc., dated as of December 16, 2013 (the “Letter Agreement”). 
 The Company will continue
to defend, indemnify and hold Executive harmless from and against any claims, losses, expenses and other matters to the fullest extent permitted by Delaware law, including Section 145 of the Delaware General Corporation Law and any other
applicable bylaw, agreement or other indemnification right of similar effect. In addition, the Company will provide at its expense tail coverage for Executive after the Separation Date under the Company’s directors and officers liability
insurance policy under the terms and for the duration set forth in Section 7.7(d) of the Agreement and Plan of Merger by and among CDRF Parent, Inc., CDRF Merger Sub, Inc., and the Company, dated as of December 16, 2013. 

4. General Release. 
 (a)
Executive (for himself and on behalf of his family members and any other person or entity who may assert a claim against any of the released parties in any way relating to, deriving from or resulting from Executive’s employment with or
separation from the Company or any services performed for the Company (including service on the Board)) (collectively, the “releasing parties”) hereby releases the Company and any successor thereto (and its officers, directors,
stockholders, employees, successors and assigns) (collectively, the “released parties”) from, waives and forever discharges and promises not to sue any of the released parties with respect to, any and all liability, loss, damage, penalty,
action, claim, judgment, settlement, cost, expense of any kind or nature whatsoever (including attorneys’ fees and interest), dispute, demand, investigation, claim, action, suit or other legal proceeding, and any order, award, decision,
injunction, judgment, ruling, or decree, whether arising in contract (oral or written), tort or any other theory of action, whether arising in law or equity, and whether known or unknown, ripe or not ripe, asserted or unasserted, from the beginning
of time up to the date of this Agreement. The claims, liabilities and other matters covered by this release include, but are not limited to, claims based on express or implied contract, compensation plans (other than as provided in
Section 4(b)(iii) below), covenants of good faith and fair dealing, wrongful discharge, claims for discrimination, harassment and retaliation, violation of public policy, any tort or common law claims, and claims of or liabilities related to
any alleged violation or breach of any federal, state, county, or local statute, ordinance or regulation, as may be amended from time to time, or common law. Such statutes include Title VII of the Civil Rights Act of 1964, 42 U.S.C. §1981, the
Age Discrimination in 

  
 3 

 
Employment Act of 1967, the Older Workers Benefit Protection Act of 1990, the Family and Medical Leave Act, the National Labor Relations Act, the Employee Retirement Income Security Act, the
Americans With Disabilities Act, the Illinois Human Rights Act, the Illinois Right to Privacy in the Workplace Act, the Illinois Equal Pay Act of 2003, and the Age Discrimination in Employment Act of 1967 (“ADEA”), the Worker
Adjustment and Retraining Notification Act (“WARN”), or equivalent state WARN act and the Employee Retirement Income Security Act, in each case as amended and all regulations and government policies and pronouncements thereunder.

 (b) Notwithstanding anything in this Agreement to the contrary, Executive is not waiving or releasing, and this Agreement does affect in
any way: 
 (i) Any right, claim or remedy of Executive that arises after the date this Agreement; 

(ii) Any right of Executive to enforce this Agreement or remedy for breach thereof; 

(iii) Any vested benefit under any employee benefit, welfare or other similar plan that the Company maintained, sponsored or contributed to
and in which Executive or his eligible dependents participated, subject to the terms and conditions of those plans; and 
 (iv) Any other
right or claim that cannot be waived or released under applicable law. 
 5. Non-Disparagement. Executive agrees not to make any
public statement that would disparage or otherwise cast the personal or professional reputation of the Company in a negative light. The Company agrees that its directors will not, and agrees to use its reasonable efforts to cause its executive
officers to not, make any public statement that would disparage or otherwise cast the personal or professional reputation of the Executive in a negative light. Nothing in this Section 5 shall be interpreted to preclude either party from making
truthful statements about the other party to the extent required by applicable law or regulation, in connection with any litigation or reasonably required in the course of any regulatory or administrative inquiry, review or investigation. 

6. Return of Property. Executive shall retain his personal files and possessions, his lap top computer, and his BlackBerry smart phone.
Except as otherwise stated in the preceding sentence, Executive will promptly return to the Company all other computers, peripherals and related equipment, cell phones and similar communication devices, keys, key cards, pass codes, and any other
tangible personal property of the Company, including without limitation files, records, reports, manuals, drawings, blueprints, prototypes, notes, documents, drawings, specifications, software, media and other materials, including any copies thereof
in Executive’s possession or under his control. 

  
 4 

 7. Withholding. All payments under this Agreement are subject to subject to normal and
customary payroll withholdings and deductions. 
 8. No Admission. Nothing in this Agreement is meant to suggest or imply that the
Company or any other released party has violated any law or contract or otherwise engaged in any wrongdoing of any kind, and this Agreement is not admissible for any purpose other than to enforce the terms hereof. This Agreement is entered into
merely to resolve any differences that might exist between the parties amicably and without the necessity or expense of further action. 

9. Successors; Assigns. This Agreement will be binding upon and inure to the benefit of the respective successors, heirs, assigns,
administrators, executors and legal representatives of the parties and the releasing and released parties. 
 10. Severability. This
Agreement shall be interpreted in such a manner as to be effective and valid under applicable law. If any of the provisions contained in this Agreement shall for any reason be held to be unenforceable or invalid, that provision shall be reformed so
that it is valid and enforceable under the circumstances which shall be substituted for the provision in question; and if the provision cannot be modified, that provision shall be severed from this Agreement and the other provisions will remain in
full force and effect 
 11. Governing Law. This Agreement is made and entered into in the State of Illinois and in all respects the
rights and obligations of the parties will be interpreted, enforced and governed in accordance with the laws of the State of Illinois without regard to the principles of conflict of laws. 

12. Entire Agreement; Amendment; Counterparts. This Agreement, the Letter Agreement and the Supplemental Employment Agreement, as
modified by this Agreement, contain the entire agreement between the Executive and the Company pertaining to the subject matter of this Agreement and fully supersede any and all prior agreements, representations and understandings between them
regarding that subject matter. Except as provided in Paragraph 10 this Agreement will not be modified or altered except by a subsequent written agreement signed by the parties; no amendment by oral agreement or course of dealing will be valid. This
Agreement may be executed in counterparts, each of which shall be binding on the party executing it and taken together shall constitute one and the same agreement. A party may deliver its signature page to this Agreement by fax or email (in a PDF
file), and any such signature page shall have the same legal effect as an original ink-signed document. The word “including,” “includes” or “include” shall be deemed to be followed by the words “without
limitation.” 

  
 5 

 13. Right to Review and Revoke this Agreement. 

(a) Executive understands that for a period of seven (7) days after he executes this Agreement, he may revoke the Agreement by delivering
to the Secretary of the Company a written statement indicating that he wishes to revoke this Agreement. This Agreement will not become enforceable or effective until the revocation period has expired without valid revocation by Executive. 

(b) Executive is advised and encouraged to consult with an attorney before signing this Agreement. Executive acknowledges and agrees that he
has carefully read and fully understands this Agreement and knowingly and voluntarily intends to be legally bound by this Agreement; he has had twenty-one (21) days in which to consider it and, if he executes this Agreement before the end of
that period he has in any event had sufficient time to consider it; has had an opportunity to ask questions and have it explained; and is entering into this Agreement freely and voluntarily. 

THIS AGREEMENT IS EXECUTED AND AGREED TO BY THE PARTIES. THIS AGREEMENT CONTAINS A GENERAL RELEASE OF CLAIMS. PLEASE READ CAREFULLY BEFORE
SIGNING. 
  

							
	Executive	 		 	PharMedium Healthcare Corporation
				
	/s/ David N. Jonas	 		 	By:	 	/s/ William R. Spalding
	David N. Jonas	 		 	Name:	 	William R. Spalding
		 		 	Title:	 	Executive Vice President

 Date signed: December 17, 2013 

  
 6EX-10.13.1

 Exhibit 10.13.1 

CDRF TOPCO, INC. 
 STOCK
INCENTIVE PLAN 
 Article I 

Purpose 
 CDRF Topco, Inc.
has established this stock incentive plan to foster and promote its long-term financial success. Capitalized terms have the meaning given in Article X. 

Article II 
 Powers of the
Board 
 Section 2.1 Power to Grant Awards. The Board shall select officers and key Employees and Directors to participate
in the Plan. The Board shall determine the terms of each Award, consistent with the Plan. 
 Section 2.2 Administration. The
Board shall be responsible for the administration of the Plan. The Board may prescribe, amend and rescind rules and regulations relating to the administration of the Plan, provide for conditions and assurances it deems necessary or advisable to
protect the interests of the Company and make all other determinations necessary or advisable for the administration and interpretation of the Plan. Any authority exercised by the Board under the Plan shall be exercised by the Board in its sole
discretion. Determinations, interpretations or other actions made or taken by the Board under the Plan shall be final, binding and conclusive for all purposes and upon all persons. 

Section 2.3 Delegation by the Board. All of the powers, duties and responsibilities of the Board specified in this Plan may be
exercised and performed by any duly constituted committee thereof to the extent authorized by the Board to exercise and perform such powers, duties and responsibilities, and any determination, interpretation or other action taken by such committee
shall have the same effect hereunder as if made or taken by the Board. 

 Article III 

Shares Subject to Plan 

Section 3.1 Number. The maximum number of shares of Common Stock that may be issued under the Plan may not exceed the sum of
(x) 37,210 shares plus (y) the total number of Exchange Shares and shares that may be issued upon the exercise of Converted Holdings Options.1 The shares of Common Stock to
be delivered under the Plan may consist, in whole or in part, of authorized but unissued shares of Common Stock that are not reserved for any other purpose. 

Section 3.2 Canceled, Terminated or Forfeited Awards; Share Counting. 

(a) Upon the grant or sale of an Award under the Plan, the remaining number of shares of Common Stock set forth in
Section 3.1 shall be reduced by the number of shares granted or sold. In the event that, subsequent to any such grant or sale, the Company reacquires any of such shares of Common Stock, such reacquired shares of Common Stock shall again be
available for grant under the Plan. 
 (b) Upon the exercise, settlement or conversion of any Award or portion thereof, there
shall again be available for grant under the Plan the number of shares subject to such Award or portion thereof minus the actual number of shares of Common Stock issued in connection with such exercise, settlement or conversion. If any such Award or
portion thereof is for any reason forfeited, canceled, expired or otherwise terminated without the issuance of shares of Common Stock, the Common Stock subject to such forfeited, canceled, expired or otherwise terminated Award or portion thereof
shall again be available for grant under the Plan. If shares of Common Stock are withheld from issuance with respect to an Award by the Company in satisfaction of any tax withholding or similar obligations, such withheld shares shall again be
available for grant under the Plan. Awards which the Board reasonably determines will be settled in cash or will be forfeited shall not reduce the Plan maximum set forth in Section 3.1. 

(c) Notwithstanding the foregoing, the share counting provisions of Sections 3.2(a) and 3.2(b) shall not apply to the Exchange
Shares and shares issued upon exercise of Converted Holdings Options. 
 Section 3.3 Adjustment upon Change in Capitalization.
If and to the extent necessary or appropriate to reflect any stock dividend, extraordinary dividend, stock split or share combination or any recapitalization, merger, consolidation, exchange of shares, spin-off, liquidation or dissolution of the
Company or other similar transaction affecting the Common Stock, the Board shall 
  

	1 	 The sum of (x) and (y) is 53,062. 

  
 2 

 
adjust the number of shares of Common Stock available for issuance under the Plan and the number, class and exercise price of outstanding Awards, and/or make such substitution, revision or other
provisions or take such other actions with respect to any outstanding Award or the holder or holders thereof, in each case as it determines to be equitable to prevent the dilution or enlargement of any Participant’s rights. Without limiting the
generality of the foregoing sentence, in the event of any such transaction, the Board shall have the power to make such changes as it deems appropriate in the number and type of shares or other securities covered by outstanding Awards, the prices
specified therein (if applicable), and the securities, cash or other property to be received upon the exercise, settlement, conversion or repurchase of such outstanding Awards or otherwise to be received in connection with such outstanding Awards.
After any adjustment made pursuant to this Section 3.3, the number of shares subject to each outstanding Award shall be rounded down to the nearest whole number. Any action taken pursuant to this Section 3.3 shall be effected in a manner
that is exempt from or otherwise complies with Section 409A of the Code. 
 Article IV 

Stock Purchase 

Section 4.1 Awards and Administration. The Board may offer and sell Common Stock to Participants at such time or times as it shall
determine, the terms of which shall be set forth in a Subscription Agreement (including, but not limited to, terms relating to the effect of Competitive Activity by a Participant). For avoidance of doubt, the Exchange Shares are not being offered or
sold pursuant to this Article IV. 
 Section 4.2 Minimum Purchase Price. Unless otherwise determined by the Board, the purchase
price for any Common Stock to be offered and sold pursuant to this Article IV shall not be less than the Fair Market Value on the Grant Date. 

Section 4.3 Payment. Unless otherwise determined by the Board, the purchase price with respect to any Common Stock offered and
sold pursuant to this Article IV shall be paid in cash or other readily available funds simultaneously with the closing of the purchase of such Common Stock. 

  
 3 

 Article V 

Terms of Options 

Section 5.1 Grant of Options. The Board may grant Options to Participants at such time or times as it shall determine. Options
granted pursuant to the Plan will not be “incentive stock options” as defined in the Code unless otherwise determined by the Board. Each Option granted to a Participant shall be evidenced by an Option Agreement that shall specify the
number of shares of Common Stock that may be purchased pursuant to such Option, the exercise price at which shares of Common Stock may be purchased pursuant to such Option, the duration of such Option (not to exceed the tenth anniversary of the
Grant Date), and such other terms as the Board shall determine (including, but not limited to, terms relating to the effect of Competitive Activity by a Participant). 

Section 5.2 Exercise Price. The exercise price per share of Common Stock to be purchased upon exercise of an Option other than a
Converted Holdings Option shall not be less than the Fair Market Value on the Grant Date. Converted Holdings Options shall have the per share exercise price specified in the applicable Rollover Agreement, which per share exercise price may be less
than the Fair Market Value. 
 Section 5.3 Vesting and Exercise of Options. Options other than Converted Holdings Options shall
become vested or exercisable in accordance with the vesting schedule or upon the attainment of such performance criteria as shall be specified by the Board on or before the Grant Date. Converted Holdings Options shall be fully vested and exercisable
at all times while they are outstanding. The Board may accelerate the vesting or exercisability of any Option, all Options or any class of Options at any time and from time to time. 

Section 5.4 Payment. The Board shall establish procedures governing the exercise of Options, which procedures shall, unless the
Board determines otherwise and/or as otherwise specified in an Award Agreement, generally require that prior written notice of exercise be given and that the exercise price (together with any required withholding taxes or other similar taxes,
charges or fees) be paid in full in cash, cash equivalents or other readily-available funds at the time of exercise. Notwithstanding the foregoing, on such terms as the Board may establish from time to time following a Public Offering
(i) the Board may permit a Participant to tender to the Company any Common Stock such Participant has owned for at least six months and one day (or such other minimum period of time necessary to avoid any adverse accounting charges) for
all or a portion of the applicable exercise price or minimum required withholding taxes and (ii) the Board may authorize the Company to establish a broker-assisted exercise program. In connection with any Option exercise, the Company may
require the Participant to furnish or execute such other documents as it shall reasonably deem necessary to (a) evidence such exercise, (b) determine whether registration is then required under the U.S. federal securities
laws or similar non-U.S. laws or (c) comply with 

  
 4 

 
or satisfy the requirements of the U.S. federal securities laws, applicable state or non-U.S. securities laws or any other law. Unless the Board determines otherwise, as a condition to the
exercise of any Option before a Public Offering, a Participant or, in the case of a Participant’s death or Disability, such other person authorized by Section 11.1 hereof, shall enter into a Subscription Agreement annexed to the Award
Agreement for the Option or, if a Subscription Agreement is not so annexed, as otherwise provided to the Participant substantially consistent with the Subscription Agreements annexed to the Award Agreements of other similarly situated Participants.

 Article VI 
 Termination of
Employment 
 Section 6.1 Expiration of Options Following Termination of Employment. Unless otherwise determined by the
Board on or before the Grant Date, or thereafter in a manner more favorable to the Participant, if a Participant’s employment with the Company terminates, such Participant’s Options shall be treated as follows: 

(a) any unvested Options shall terminate effective as of such termination of employment; provided that if the
Participant’s employment with the Company is terminated in a Special Termination (i.e., by reason of the Participant’s death or Disability), any unvested Options held by the Participant shall immediately vest as of the effective date of
such Special Termination; 
 (b) except in the case of a termination for Cause, vested Options shall remain exercisable
through the earliest of (i) the normal expiration date, (ii) 90 days after the Participant’s termination of employment or 180 days in the case of a Special Termination or Retirement, and (iii) any
cancellation pursuant to Section 7.1; and 
 (c) in the case of a termination for Cause, any and all Options held by
such Participant (whether or not then vested or exercisable) shall terminate immediately upon such termination of employment; provided, that the effect of a termination for Cause on Converted Holdings Options shall be as set forth in the
Option Agreement evidencing such Converted Holdings Options. 

  
 5 

 Section 6.2 Call Rights upon Termination of Employment Prior to a Public Offering.
Unless otherwise determined by the Board on or before the Grant Date, or thereafter in a manner more favorable to the Participant, each Subscription Agreement shall provide that the Company and one or more of the Investors shall have successive
rights prior to a Public Offering to purchase all or any portion of a Participant’s Common Stock upon any termination of employment, at such time and at a purchase price per share equal to the Fair Market Value as of the date specified in the
Subscription Agreement (or, if the Participant’s employment termination qualifies as a termination for Cause, for a purchase price per share equal to the lesser of (i) the Fair Market Value as of the date specified in the
Subscription Agreement and (ii) such Participant’s per share purchase price; provided, that the effect of a termination for Cause on shares of Common Stock acquired upon exercise of a Converted Holdings Option shall be as set
forth in the Subscription Agreement applicable to such shares of Common Stock). Without limiting the generality of this Section 6.2 or of the administrative powers of the Board or its delegate hereunder, the Company may require, as a condition
to the acquisition of any Common Stock under the Plan, that (i) the Participant execute and deliver an undated stock power, duly executed in blank, for the shares and a power of attorney, in each case to effectuate the purchase described
herein, and (ii) the Participant’s spouse execute and deliver a form of spousal waiver with respect to such shares. 

Article VII 
 Change in
Control 
 Section 7.1 Accelerated Vesting and Payment. Except as otherwise provided in this Article VII or in the Option
Agreement, upon a Change in Control, each Option, whether vested or unvested, shall be canceled in exchange for a payment in an amount or with a value equal to the excess, if any, of the Change in Control Price over the exercise price for such
Option. 
 Section 7.2 Alternative Award. No cancellation, acceleration or other payment shall occur with respect to any Option
if the Board reasonably determines in good faith, prior to the occurrence of a Change in Control, that such Option shall be honored or assumed, or new rights substituted therefor following the Change in Control (such honored, assumed or substituted
award, an “Alternative Award”), provided that any Alternative Award must: 
 (a) give the Participant
who held such Option rights and entitlements substantially equivalent to or better than the rights and terms applicable under such Option, including, but not limited to, an identical or better exercise and vesting schedule, and identical or better
timing and methods of payment; and 

  
 6 

 (b) have terms such that if a Participant’s employment is involuntarily
(i.e., by the Company or its successor other than for Cause) or constructively (i.e., by the Participant with “good reason”, which, for a Participant who is a party to an employment agreement that contains such term, shall be as defined in
such employment agreement, and, for a Participant who is not a party to an employment agreement containing such term, shall be determined by the Board prior to the Change in Control so as to be reasonably protective of the Participant in light of
the circumstances of the particular transaction) terminated within two years following a Change in Control at a time when any portion of the Alternative Award is unvested, the unvested portion of such Alternative Award shall immediately vest in full
and such Participant shall receive (as determined by the Board prior to the Change in Control) either (1) a cash payment equal in value to the excess (if any) of the fair market value of the stock subject to the Alternative Award at the
date of exercise or settlement over the price (if any) that such Participant would be required to pay to exercise such Alternative Award or (2) publicly-traded shares or equity interests equal in value equal to the value in clause (1).

 Any Alternative Award shall either be exempt from, or otherwise comply with, Section 409A of the Code. 

Section 7.3 Limitation of Benefits. Unless otherwise provided in the Award Agreement, if, whether as a result of accelerated
vesting, the grant of an Alternative Award or otherwise, a Participant would receive any payment, deemed payment or other benefit as a result of the operation of Section 7.1 or Section 7.2 that, together with any other payment, deemed
payment or other benefit a Participant may receive under any other plan, program, policy or arrangement, would constitute an “excess parachute payment” under section 280G of the Code, then, notwithstanding anything in this Plan to the
contrary, the payments, deemed payments or other benefits such Participant would otherwise receive under Section 7.1 or Section 7.2 shall be reduced to the extent necessary to eliminate (or, if not able to be completely eliminated, to the
extent necessary to be mitigated to the maximum extent practicable) any such excess parachute payment and such Participant shall have no further rights or claims with respect thereto. If the preceding sentence would result in a reduction of the
payments, deemed payments or other benefits a Participant would otherwise receive in more than an immaterial amount, the Company will (1) at the expense of the Company, engage a nationally recognized accounting firm selected by it to
make the analysis and calculations required to determine the effects of Section 280G of the Code on such payments, deemed payments or other benefits, (2) submit payment of the reduced payments to the Company’s shareholders for
approval in the manner provided for in section 

  
 7 

 
280G(b)(5) of the Code and the regulations thereunder with respect to such reduced payments or other benefits (if the Company is eligible to do so), so that, if such shareholder approval is
obtained, such payments would not be treated as “parachute payments” for these purposes (and therefore would cease to be subject to reduction pursuant to this Section 7.3) and (3) will use commercially reasonable efforts
to obtain such approval. 
 Article VIII 

Authority to Vary Terms or Establish Local Jurisdiction Plans 

The Board may vary the terms of new Awards under the Plan for different Participants or groups of Participants prior to grant, or establish
sub-plans under this Plan to authorize the grant of awards that have additional or different terms or features from those otherwise provided for in the Plan, if and to the extent the Board determines necessary or appropriate to permit the grant of
awards that are best suited to further the purposes of the Plan and to comply with applicable securities laws in a particular jurisdiction or provide terms appropriately suited for Participants in such jurisdiction in light of the tax laws of such
jurisdiction while being as consistent as otherwise possible with the terms of Awards under the Plan; provided that this Article VIII shall not be deemed to authorize any increase in the number of shares of Common Stock available for issuance
under the Plan set forth in Section 3.1. 
 Article IX 

Amendment, Modification, and Termination of the Plan 

The Board may terminate or suspend the Plan at any time, and may amend or modify the Plan from time to time. No amendment, modification,
termination or suspension of the Plan shall have a substantial adverse effect on the economic terms of any Award theretofore granted under the Plan without the consent of the Participant holding such Award or the consent of a majority of
Participants holding similar Awards under the Plan (such majority to be determined based on the number of shares covered by such Awards); provided, that no such amendment, modification, termination or suspension of the Plan may single out a
Participant, individually or as a class, for such effect without the affected Participant’s consent. Shareholder approval of any such amendment, modification, termination or suspension shall be obtained to the extent mandated by applicable law,
or if otherwise deemed appropriate by the Board. 

  
 8 

 Article X 

Definitions 

Section 10.1 Definitions. Whenever used herein, the following terms shall have the respective meanings set forth below: 

“Affiliate” shall mean, with respect to any Person, any other Person directly or indirectly controlling,
controlled by or under common control with such first Person; provided that a director, member of management or other employee of the Company or any Subsidiary shall not be deemed to be an Affiliate of any of the Investors. For these
purposes, “control” (including the terms “controlled by” and “under common control with”) means the possession, directly or indirectly, of the power to direct or cause the direction of the management policies of a
Person by reason of ownership of voting securities, by contract or otherwise. 
 “Alternative Award” has the
meaning given in Section 7.2. 
 “Award” shall mean an Option or an offer and sale of Common Stock
pursuant to Article IV, in each case granted pursuant to the terms of the Plan. 
 “Award Agreement” means a
Subscription Agreement, an Option Agreement or any other agreement evidencing an Award. 
 “Board” means the
Board of Directors of the Company or, to the extent that a delegation to a committee has occurred as provided in Section 2.3, such committee (to the extent of such delegation). 

“Cause” shall, as to any Participant, have the same meaning as set forth in the employment agreement to which
the Participant is a party with the Company or an Affiliate that contains a definition of “Cause”, or, in the absence of such an employment agreement or such definition in an employment agreement, shall mean any of the following:
(i) the Participant’s commission of a crime involving fraud, theft, false statements or other similar acts or commission of any crime that is a felony (or a comparable classification in a jurisdiction that does not use these terms);
(ii) the Participant’s engaging in any conduct that constitutes an employment disqualification under applicable law with respect to a material portion of the Participant’s work duties; (iii) the Participant’s
willful or grossly negligent failure to perform his or her employment-related duties for the Company and the Subsidiaries, or willful misconduct in the 

  
 9 

 
performance of such duties; (iv) the Participant’s material violation of any Company or Subsidiary policy as in effect from time to time; (v) the Participant’s
engaging in any act or making any statement that materially impairs, impugns, denigrates, disparages or negatively reflects upon the name, reputation or business interests of the Company or the Subsidiaries; or (vi) the
Participant’s material breach of any Award Agreement, employment agreement, or noncompetition, nondisclosure or nonsolicitation agreement to which the Participant is a party or by which the Participant is bound. Prior to effecting the
termination of employment of a Participant for gross negligence under clause (iii) or pursuant to clause (iv), (v) or (vi), the Board shall reasonably determine whether the alleged conduct is reasonably susceptible of cure, and, if
curable, the Company shall provide the Participant with the opportunity to cure such conduct. The determination as to whether “Cause” has occurred shall be made by the Board, acting reasonably and in good faith, and the Board shall have
the authority to waive the consequences under the Plan of the existence or occurrence of any of the events, acts or omissions constituting “Cause.” A termination for Cause shall be deemed to include a determination following a
Participant’s termination of employment for any reason that circumstances existing prior to such termination for the Company or one of the Subsidiaries to have terminated such Participants employment for Cause; provided, that such
determination shall be made not later than thirty (30) days following the date on which the Board first has actual knowledge of the relevant conduct (and, for avoidance of doubt, if the Board undertakes an internal investigation of such
conduct, the Board shall not be deemed to have actual knowledge of such conduct until the conclusion of such investigation). 

“Change in Control” means the first to occur of the following events after the Effective Date: 

(i) the acquisition by any person, entity or “group” (as defined in Section 13(d) of the Securities Exchange Act
of 1934, as amended) of more than 50% of the combined voting power of the Company’s then outstanding voting securities, other than any such acquisition by the Company, any of the Subsidiaries, any employee benefit plan of the Company or any of
the Subsidiaries, or by any of the Investors, or any Affiliates of any of the foregoing; 
 (ii) the merger, consolidation or
other similar transaction involving the Company, as a result of which both (x) persons who were stockholders of the Company immediately prior to such merger, consolidation, or other similar transaction do not,

  
 10 

 
immediately thereafter, own, directly or indirectly, more than 50% of the combined voting power entitled to vote generally in the election of directors of the merged or consolidated company, and
(y) any or all of the Investors (individually or collectively) do not, immediately thereafter, own, directly or indirectly, more than 50% of the combined voting power entitled to vote generally in the election of directors of the merged
or consolidated company; 
 (iii) within any 12-month period, the persons who were directors of the Company at the beginning
of such period (the “Incumbent Directors”) shall cease to constitute at least a majority of the Board, provided that any director elected or nominated for election to the Board by a majority of the Incumbent Directors then
still in office shall be deemed to be an Incumbent Director for purposes of this clause (iii); or 
 (iv) the sale, transfer
or other disposition of all or substantially all of the assets of the Company to one or more persons or entities that are not, immediately prior to such sale, transfer or other disposition, Affiliates of the Company. 

Notwithstanding the foregoing, a Public Offering shall not constitute a Change in Control. 

“Change in Control Price” means the price per share of Common Stock offered in conjunction with any
transaction resulting in a Change in Control. If any part of the offered price is payable other than in cash, the equivalent to the cash Change in Control Price shall be determined in good faith by the Board as constituted immediately prior to the
Change in Control. 
 “Code” means the United States Internal Revenue Code of 1986, as amended, and any
successor thereto. 
 “Common Stock” means the Common Stock, par value U.S. $0.01 per share, of the Company
and, if applicable, any securities which may be issued after the Effective Date in respect of, or in exchange for, the shares of Common Stock. 

“Company” means CDRF Topco, Inc., a Delaware corporation, and any successor thereto; provided that for
purposes of determining the status of a Participant’s employment with the “Company,” such term shall include the Company and/or any of the Subsidiaries or Affiliates that employ the Employee. 

  
 11 

 “Competitive Activity” with respect to a Participant means the
Board’s determination, made reasonably and in good faith, that the Participant, directly or indirectly, has engaged in conduct constituting a material breach of any agreement to which the Participant, on the one hand, and the Company or any of
its Affiliates, on the other hand, are parties that prohibits or otherwise limits or conditions actions of the Participant related to competition, interference with key business relationships, solicitation of customers or employees, disclosure of
confidential information, ownership of intellectual property, disparagement, and other similar activities, in each case by Participant. 

“Converted Holdings Options” has the same meaning, with respect any Participant, as set forth in the
applicable Rollover Agreement. 
 “Director” means a non-employee member of the Board. 

“Disability” means, unless otherwise provided in an Award Agreement, a Participant’s long-term disability
within the meaning of the long-term disability insurance plan or program of the Company or any Subsidiary then covering the Participant, or in the absence of such a plan or program, Participant’s actual or prospective inability to perform his
duties for any period of 180 consecutive days as determined by the Board. The Board’s reasoned and good faith judgment of Disability shall be final and shall be based on such competent medical evidence as shall be presented to it by the
Participant or by any physician or group of physicians or other competent medical expert employed by the Participant or the Company to advise the Board. Notwithstanding the foregoing, for any Award that is subject to Section 409A of the Code,
“Disability” shall have the same meaning as set forth in Section 409A of Code. 
 “Effective
Date” has the meaning given in Section 11.10. 
 “Employee” means any executive, officer or
other employee of the Company or any Subsidiary. 
 “Exchange Shares” has the same meaning, with respect any
Participant, as set forth in the applicable Rollover Agreement. 

  
 12 

 “Fair Market Value” means, as of any date of determination prior
to a Public Offering, the per share fair market value on such date of a share of Common Stock as determined reasonably and in good faith by the Board, in compliance with section 409A of the Code. In making a determination of Fair Market Value, the
Board shall give due consideration to any recent valuation of the Common Stock that shall have been performed by an independent valuation firm (although nothing herein shall obligate the Board to obtain any such independent valuation). Following a
Public Offering, “Fair Market Value” shall mean, as of any date of determination, the mid-point between the high and the low trading prices for such date per share of Common Stock as reported on the principal stock exchange on which the
shares of Common Stock are then listed. 
 “Financing Agreements” means any guaranty, financing or security
agreement or document entered into by the Company or any Subsidiary from time to time with any Person other than an Investor or one of its Affiliates. 

“Grant Date” means, with respect to any Award, the date as of which such Award is granted pursuant to the
Plan. 
 “Investor” means any of Clayton, Dubilier & Rice Fund IX, L.P.; CD&R Advisor Fund IX,
L.P.; and CD&R Forest Holdings. L.P. 
 “Option” means the right granted pursuant to the Plan to
purchase one share of Common Stock. 
 “Option Agreement” means an agreement between the Company and a
Participant embodying the terms of any Options granted pursuant to the Plan and in the form approved by the Board from time to time for such purpose. 

“Participant” means any Employee or Director who is granted an Award. 

“Person” means any natural person, firm, partnership, limited liability company, association, corporation,
company, trust, business trust, governmental authority or other entity. 
 “Plan” means this CDRF Topco,
Inc. Stock Incentive Plan. 

  
 13 

 “Public Offering” means the first day as of which
(i) (a) there has occurred an initial public offering of Common Stock pursuant to an effective registration statement under the Securities Act and (b) the aggregate value of shares of Common Stock trading on a
public market is at least $100 million, or (ii) the Board has determined that shares of the Common Stock otherwise have become publicly-traded for this purpose, which shall occur not later than the first date on which the aggregate value
of shares of Common Stock sold to the public (whether in a Public Offering or subsequent public offerings) is at least $100 million. 

“Retirement” means any termination of a Participant’s employment at or after age 65, excluding a
termination by the Company for Cause. 
 “Rollover Agreement” means, with respect any Participant, the
Exchange Agreement to which the Company and such Participant are parties. 
 “Securities Act” means the
Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder. 
 “Special
Termination” means a termination by reason of the Participant’s death or Disability. 
 “Subscription
Agreement” means a stock subscription agreement between the Company and a Participant embodying the terms of any stock purchase made pursuant to the Plan and in the form approved by the Board from time to time for such purpose. 

“Subsidiary” means any corporation, limited liability company or other entity, a majority of whose outstanding
voting securities is owned, directly or indirectly, by the Company. 
 Section 10.2 Rules of Construction. 

(a) Gender and Number. Except when otherwise indicated by the context, words in the masculine gender used in the Plan
shall include the feminine gender, the singular shall include the plural, and the plural shall include the singular. 
 (b)
Use of the term “Employ”. The words “employment”, “employ” and corollary terms used herein and in an Award Agreement with respect to a Director shall be construed to refer to the Director’s service as a
non-employee member of the Board. The phrase “employment with the Company” and corollary terms used herein and in an Award Agreement 

  
 14 

 
with respect to an Employee shall be construed to refer to the employment with the Company and/or the Affiliates of the Company that actually employ the Employee. For purposes of this Agreement,
unless the Board determines otherwise or applicable law requires otherwise, (1) the transfer of employment of an Employee as between the Company and any of its Affiliates shall not be treated as a termination of employment, and
(2) if an Employee ceases to be an employee but continues to provide services to the Company in any capacity, his or her “employment” shall be deemed to continue during the provision of such services. 

(c) Termination of Employment. It shall be condition of each Award under the Plan that the date of termination of a
Participant’s employment shall be determined without regard to any statutory or deemed or express contractual notice period, unless otherwise required by law. 

Article XI 
 Miscellaneous
Provisions 
 Section 11.1 Nontransferability of Awards. Except as otherwise provided herein, in a Subscription Agreement or
as the Board may permit on such terms as it shall determine, no Awards granted under the Plan may be sold, transferred, pledged, assigned, hedged, encumbered or otherwise alienated or hypothecated, other than by will or by the laws of descent and
distribution. All rights with respect to Awards granted to a Participant under the Plan shall be exercisable during the Participant’s lifetime by such Participant only (or, in the event of the Participant’s Disability, such
Participant’s legal representative). Following a Participant’s death, all rights with respect to Awards that were outstanding at the time of such Participant’s death and have not terminated shall be exercised by his designated
beneficiary or by his estate in the absence of a designated beneficiary. 
 Section 11.2 Tax Withholding. The Company or the
Subsidiary employing a Participant shall have the power to withhold up to the minimum statutory requirement, or to require such Participant to remit to the Company or such Subsidiary, an amount sufficient to satisfy all U.S. federal, state, local
and any non-U.S. withholding tax or other governmental tax, charge or fee requirements in respect of any Award granted under the Plan. 

Section 11.3 Beneficiary Designation. Pursuant to such rules and procedures as the Board may from time to time establish, a
Participant may name a beneficiary or beneficiaries (who may be named contingently or successively) by whom any right under the Plan is to be exercised in case of such Participant’s 

  
 15 

 
death. Each designation will revoke all prior designations by the same Participant, shall be in a form reasonably prescribed by the Board, and will be effective only when filed by the Participant
in writing with the Company during his or her lifetime. 
 Section 11.4 No Guarantee of Employment or Participation. Nothing in
the Plan or in any agreement granted hereunder shall interfere with or limit in any way the right of the Company or any Subsidiary to terminate any Participant’s employment or retention at any time, or confer upon any Participant any right to
continue in the employ or retention of the Company or any Subsidiary. No individual shall have a right to be selected as a Participant or, having been so selected, to receive any other or future Awards. 

Section 11.5 No Limitation on Compensation; No Impact on Benefits. Nothing in the Plan shall be construed to limit the right of
the Company or any Subsidiary to establish other plans or to pay compensation to its Employees, in cash or property, in a manner that is not expressly authorized under the Plan. Except as may otherwise be specifically and unequivocally stated under
any employee benefit plan, policy or program, no amount payable in respect of any Award shall be treated as compensation for purposes of calculating a Participant’s rights under any such plan, policy or program. The selection of an Employee as
a Participant shall neither entitle such Employee to, nor disqualify such Employee from, participation in any other award or incentive plan. 

Section 11.6 No Voting Rights. Except as otherwise required by law, no Participant holding any Awards granted under the Plan shall
have any right in respect of such Awards to vote on any matter submitted to the Company’s stockholders until such time as the shares of Common Stock underlying such Awards have been issued, and then subject to the voting restrictions contained
in the Subscription Agreement. 
 Section 11.7 Requirements of Law. The granting of Awards and the issuance of shares of Common
Stock pursuant to the Plan shall be subject to all applicable laws, rules and regulations, and to such approvals by any governmental agencies or national securities exchanges as may be required. No Awards shall be granted under the Plan, and no
Common Stock shall be issued under the Plan, if such grant or issuance would result in a violation of applicable law, including U.S. federal securities laws and any applicable state or non-U.S. securities laws. 

Section 11.8 Freedom of Action. Nothing in the Plan or any Award Agreement evidencing an Award shall be construed as limiting or
preventing the Company or any Subsidiary from taking any corporate action (such as 

  
 16 

 
acquisitions, dispositions, entry into new lines of business and the incurrence of indebtedness) that it deems appropriate or in its best interest (as determined in its sole and absolute
discretion) and no Participant (or person claiming by or through a Participant) shall have any right relating to the diminishment in the value of any Award as a result of any such action, so long as such action is not directly governed by or is not
directly related to the administration of the Plan or any Award Agreement. This Section 11.8 shall not be construed to enlarge the rights of the Company or the Board hereunder with respect to the interpretation or administration of the Plan or
any Award Agreements. 
 Section 11.9 Unfunded Plan; Plan Not Subject to ERISA. The plan is an unfunded plan and Participants
shall have the status of unsecured creditors of the Company. The Plan is not intended to be subject to the Employee Retirement Income and Security Act of 1974, as amended. 

Section 11.10 Term of Plan. The Plan shall be effective as of the “Closing Date” (as defined in the Rollover Agreements)
(the “Effective Date”) and shall continue in effect, unless sooner terminated pursuant to Article IX, until the tenth anniversary of such date. The provisions of the Plan shall continue thereafter to govern all outstanding Awards.

 Section 11.11 Governing Law. The Plan, and all agreements hereunder, shall be governed by and construed in accordance with
the law of the State of Delaware regardless of the application of rules of conflict of law that would apply the laws of any other jurisdiction. 

Section 11.12 Section 409A of the Code. This Plan and the Award Agreements entered into pursuant to this Plan are intended to
be exempt from or comply with the requirements of Section 409A of the Code and shall be construed and interpreted in accordance with such intent. 

  
 17

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00249-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00249-of-00352.parquet"}]]